As a doctor, I know that any flu can cause asthma like symptoms. It is disturbing that Relenza can make asthma symptoms worse which is the exact opposite you'd want if someone was having flu in the lungs.
0609 GMT [Dow Jones] Nomura upgrades GlaxoSmithKline (GSK) to buy from neutral. Says the company is currently limited in the supply of antiviral Relenza to around 0.5M-1M treatments a year. But new data suggest the company could raise output to 41M treatment courses per annum by 2008. At an estimated price of $33 per course, this could deliver an additional $1.4B in annual revenue. Shares closed at 1,445p. (EXB)
canny said:USA releases figures today (Wednesday our time probably) of how they are spending their massive budget on bird flu prevention.
Relenza is expected to get a decent chunk of the action, as anti viral stockpiling is still considered the best in the first line of medical defence.
Keep an eye on CNN news pages for the updates - but that's probably why the price has been holding so well - this US order may open another round of the floodgates, with other countries following suit.
http://edition.cnn.com/2005/HEALTH/conditions/10/31/us.flu.plan/index.html
Hello and welcome to Aussie Stock Forums!
To gain full access you must register. Registration is free and takes only a few seconds to complete.
Already a member? Log in here.